Table 1.
Level of documented screening for the metabolic syndrome (MS) in the total national sample at each audit from 2006 to 2012
| Clinical audit |
||||||
|---|---|---|---|---|---|---|
| 2006 | 2007 | 2008 | 2009 | 2010 | 2012 | |
| Number of participating Trusts | 21 | 21 | 13 | 21 | 29 | 32 |
| Number of participating clinical teams | 48 | 35 | 28 | 56 | 76 | 100 |
| Number of patients in sample | 1966 | 1516 | 1035 | 2522 | 3058 | 1591 |
| No evidence of MS screening | 46% | 25% | 31% | 28% | 27% | 14% |
| Some evidence of MS screening | 43% | 52% | 50% | 50% | 49% | 52% |
| Test result documented for all four aspects of MS | 11% | 23% | 18% | 22% | 24% | 34% |